Real-time enrollment status for this chronic lymphocytic leukemia (cll) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:49 AM UTC
| NCT Number | NCT04830137 |
| Recruiting Status | Recruiting |
| Condition | Chronic Lymphocytic Leukemia (CLL) |
| Phase | Clinical Trial |
| Target Enrollment | 248 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Nurix Therapeutics, Inc. |
| Last Updated on CT.gov | March 20, 2026 (Mar 20, 2026) |
As of July 13, 2026: Clinical trial NCT04830137 is currently recruiting participants. This clinical trial study for chronic lymphocytic leukemia (cll) is actively seeking new participants at 16 locations across the United States. The study is sponsored by Nurix Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04830137 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04830137 was last updated Mar 20, 2026 (March 20, 2026). HelloStudys verifies this status automatically.